1887

Abstract

In this study, we describe the frequency of virulence genes in Klebsiella pneumoniae carbapenemase-2-producing Klebsiella pneumoniae (KPC-KP), including hypervirulent (hv) and hypermucoviscous (hm) strains by whole-genome sequencing. We also evaluate the capacity for biofilm formation by using phenotypic techniques. The occurrence of several virulence genes (fimABCDEFGHIK, mrkABCDFHJ, ecpA, wabG, entB, ugE, irp1, irp2, traT, iutA and ureADE) and a high frequency of hvhmKPC-KP isolates was found. Most hospital-associated lineages of KPC-KP belong to the international clonal group 258 (CG258). Biofilm formation was a constant feature among 90.9 % of KPC-KP strains. This report suggests a close relationship between ST437 and weak biofilm production, given that all weakly biofilm-producing strains belonged to this sequence type. This also supports the dissemination of KPC-KP containing numerous virulence determinants belonging to the biofilm-producing CG258 type in Brazil, including hv and hm strains. These factors allow this pathogen to cause infections, leading to its rapid expansion and persistence in hospital settings.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000711
2018-03-06
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/4/523.html?itemId=/content/journal/jmm/10.1099/jmm.0.000711&mimeType=html&fmt=ahah

References

  1. Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect 2018;24:133–144 [CrossRef][PubMed]
    [Google Scholar]
  2. Labarca J, Poirel L, Ozdamar M, Turkoglü S, Hakko E et al. KPC-producing Klebsiella pneumoniae, finally targeting Turkey. New Microbes New Infect 2014;2:50–51 [CrossRef][PubMed]
    [Google Scholar]
  3. D'Andrea MM, Marmo P, Henrici de Angelis L, Palmieri M, Ciacci N et al. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage. Sci Rep 2017;7:2614 [CrossRef][PubMed]
    [Google Scholar]
  4. Diago-Navarro E, Calatayud-Baselga I, Sun D, Khairallah C, Mann I et al. Antibody-based immunotherapy to treat and prevent infection with hypervirulent Klebsiella pneumoniae. Clin Vaccine Immunol 2017;24:e00456-16 [CrossRef][PubMed]
    [Google Scholar]
  5. Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes?. Virulence 2017;8:1111–1123 [CrossRef][PubMed]
    [Google Scholar]
  6. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017;8:460–469 [CrossRef][PubMed]
    [Google Scholar]
  7. Cassat JE, Semltzer MS, Lee CY. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. MTDS Mol Biol 2014;1085:195–211
    [Google Scholar]
  8. de Campos PA, Royer S, Batistão DW, Araújo BF, Queiroz LL et al. Multidrug resistance related to biofilm formation in Acinetobacter baumannii and Klebsiella pneumoniae clinical strains from different pulsotypes. Curr Microbiol 2016;72:617–627 [CrossRef][PubMed]
    [Google Scholar]
  9. Saxena S, Banerjee G, Garg R, Singh M. Comparative study of biofilm formation in Pseudomonas aeruginosa isolates from patients of lower respiratory tract infection. J Clin Diagn Res 2014;8:DC09–DC11 [CrossRef][PubMed]
    [Google Scholar]
  10. Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis 2015;28:375–383 [CrossRef][PubMed]
    [Google Scholar]
  11. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013;13:785–796 [CrossRef][PubMed]
    [Google Scholar]
  12. Ribeiro PC, Monteiro AS, Marques SG, Monteiro SG, Monteiro-Neto V et al. Phenotypic and molecular detection of the blaKPCgene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil. BMC Infect Dis 2016;16:737 [CrossRef][PubMed]
    [Google Scholar]
  13. Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD et al. A two-year surveillance in five colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother 2015;60:332–342 [CrossRef][PubMed]
    [Google Scholar]
  14. Pereira PS, de Araujo CF, Seki LM, Zahner V, Carvalho-Assef AP et al. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother 2013;68:312–316 [CrossRef][PubMed]
    [Google Scholar]
  15. Seki LM, Pereira PS, de Souza MP, Conceição MS, Marques EA et al. Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis 2011;70:274–277 [CrossRef][PubMed]
    [Google Scholar]
  16. Lavigne JP, Cuzon G, Combescure C, Bourg G, Sotto A et al. Virulence of Klebsiella pneumoniae isolates harboring blaKPC-2 carbapenemase gene in a Caenorhabditis elegans model. PLoS One 2013;8:e67847 [CrossRef][PubMed]
    [Google Scholar]
  17. Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 2015;59:5873–5884 [CrossRef][PubMed]
    [Google Scholar]
  18. Liu Y, Liu PP, Wang LH, Wei DD, Wan LG et al. Capsular polysaccharide types and virulence-related traits of epidemic KPC-Producing Klebsiella pneumoniae isolates in a Chinese University Hospital. Microb Drug Resist 2017;23:901–907 [CrossRef][PubMed]
    [Google Scholar]
  19. Gu D, Dong N, Zheng Z, Lin D, Huanf M et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2017;3099:30489–9
    [Google Scholar]
  20. Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 2014;78:510–543 [CrossRef][PubMed]
    [Google Scholar]
  21. Naparstek L, Carmeli Y, Navon-Venezia S, Banin E. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 2014;69:1027–1034 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000711
Loading
/content/journal/jmm/10.1099/jmm.0.000711
Loading

Data & Media loading...

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error